Characterization of the neuraminidase genes from human influenza A viruses circulating in Iran from 2010 to 2015

dc.contributor.authorMoasser, Elham
dc.contributor.authorBehzadian, Farida
dc.contributor.authorMoatari, Afagh
dc.contributor.authorFotouhi, Fatemeh
dc.contributor.authorZaraket, Hassan
dc.contributor.departmentExperimental Pathology, Microbiology, and Immunology
dc.contributor.departmentSpecialized Clinical Programs and Services
dc.contributor.departmentCenter for Infectious Diseases Research
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:38:57Z
dc.date.available2025-01-24T11:38:57Z
dc.date.issued2018
dc.description.abstractBackground: Characterization of influenza viruses is critical for detection of new emerging variants. Herein, we analyzed the genetic diversity and drug susceptibility of the neuraminidase gene (NAs) expressed by influenza A/H1N1pdm09 and A/H3N2 viruses circulating in Iran from 2010 to 2015. Methods: We genetically analyzed the NAs of 38 influenza A/H1N1pdm09 and 35 A/H3N2 isolates. Results: The Iranian A/H1N1pdm09 viruses belonged to seven genogroups/subgenogroups, with the dominant groups being genogroups 6B and 6C. The A/H3N2 isolates fell into six gneogroups/subgenogroups, with the dominant genogroups being 3C and 3C.2a. The most common mutations detected among the A/H1N1pdm09 viruses included N44S, V106I, N200S, and N248D. All H1N1pdm09 viruses were genetically susceptible to the NAIs. However, one A/H1N1pdm09 virus from the 2013–2014 season possessed an NA-S247N mutation, which reduces the susceptibility to oseltamivir. In case of H3N2, none of the analyzed Iranian strains carried a substitution that might affect its susceptibility to NAIs. Conclusion: The ongoing evolution of influenza viruses and the detect of influenza viruses with reduced susceptibility to NAIs warrants continuous monitoring of the circulating strains. © 2017, Springer-Verlag GmbH Austria.
dc.identifier.doihttps://doi.org/10.1007/s00705-017-3603-y
dc.identifier.eid2-s2.0-85041691897
dc.identifier.pmid29086107
dc.identifier.urihttp://hdl.handle.net/10938/29126
dc.language.isoen
dc.publisherSpringer-Verlag Wien
dc.relation.ispartofArchives of Virology
dc.sourceScopus
dc.subjectA/h1n1pdm09
dc.subjectA/h3n2
dc.subjectAntiviral resistance
dc.subjectInfluenza
dc.subjectIran
dc.subjectMolecular genetic analysis
dc.subjectAntiviral agents
dc.subjectHumans
dc.subjectInfluenza a virus, h1n1 subtype
dc.subjectInfluenza a virus, h3n2 subtype
dc.subjectInfluenza, human
dc.subjectMutation, missense
dc.subjectNeuraminidase
dc.subjectOseltamivir
dc.subjectPhylogeny
dc.subjectViral proteins
dc.subjectAntivirus agent
dc.subjectNa protein, influenza a virus
dc.subjectSialidase
dc.subjectViral protein
dc.subjectAntagonists and inhibitors
dc.subjectClassification
dc.subjectDrug effects
dc.subjectEnzymology
dc.subjectGenetics
dc.subjectHuman
dc.subjectInfluenza a virus (h1n1)
dc.subjectInfluenza a virus (h3n2)
dc.subjectMetabolism
dc.subjectMissense mutation
dc.subjectVirology
dc.titleCharacterization of the neuraminidase genes from human influenza A viruses circulating in Iran from 2010 to 2015
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2018-4343.pdf
Size:
1.08 MB
Format:
Adobe Portable Document Format